Therapeutics targeting the fibrinolytic system

H Lin, L Xu, S Yu, W Hong, M Huang… - Experimental & molecular …, 2020 - nature.com
The function of the fibrinolytic system was first identified to dissolve fibrin to maintain
vascular patency. Connections between the fibrinolytic system and many other physiological …

The kallikrein-kinin system: current and future pharmacological targets

ME Moreau, N Garbacki, G Molinaro… - Journal of …, 2005 - jstage.jst.go.jp
The kallikrein-kinin system is an endogenous metabolic cascade, triggering of which results
in the release of vasoactive kinins (bradykinin-related peptides). This complex system …

The urokinase plasminogen activator system in cancer: recent advances and implication for prognosis and therapy

N Sidenius, F Blasi - Cancer and Metastasis Reviews, 2003 - Springer
Cancer dissemination and metastasis is synonymous with invasive cell migration; a process
in which the extracellular matrix (ECM) plays the dual role of the substratum on which the …

Pathways for bradykinin formation and inflammatory disease

AP Kaplan, K Joseph, M Silverberg - Journal of allergy and clinical …, 2002 - Elsevier
Bradykinin is formed by the interaction of factor XII, prekallikrein, and high-molecular-weight
kininogen on negatively charged inorganic surfaces (silicates, urate, and pyrophosphate) or …

Organization, evolution and functions of the human and mouse Ly6/uPAR family genes

CL Loughner, EA Bruford, MS McAndrews, EE Delp… - Human genomics, 2016 - Springer
Members of the lymphocyte antigen-6 (Ly6)/urokinase-type plasminogen activator receptor
(uPAR) superfamily of proteins are cysteine-rich proteins characterized by a distinct disulfide …

The hemostatic system as a regulator of angiogenesis

T Browder, J Folkman, S Pirie-Shepherd - Journal of Biological Chemistry, 2000 - ASBMB
Angiogenesis is the process of sprouting and configuring new blood vessels from pre-
existing blood vessels, whereas the hemostatic system maintains the liquid flow of blood by …

Role of vitronectin and its receptors in haemostasis and vascular remodeling

KT Preissner, D Seiffert - Thrombosis research, 1998 - thrombosisresearch.com
Corresponding aulhor: Klaus T. Preissner, Haemostasis Research Unit, Kerckhoff-Klinik,
MPI, Sprudelhof 11, D-61231 Bad Nauheim, Germany; Tel+ 49-6032-996-719; Fax+ 49 …

The plasma bradykinin-forming pathways and its interrelationships with complement

AP Kaplan, B Ghebrehiwet - Molecular immunology, 2010 - Elsevier
The plasma bradykinin-forming cascade and the complement pathways share many
elements, including cross-activation, common control mechanisms, and shared binding …

uPAR–uPA–PAI-1 interactions and signaling: a vascular biologist's view

BR Binder, J Mihaly, GW Prager - Thrombosis and haemostasis, 2007 - thieme-connect.com
The urokinase-type plasminogen activator (uPA), its inhibitor PA I-1 and its cellular receptor
(uPAR), play a pivotal role in pericellular proteolysis. In addition, through their interactions …

Identification and characterization of prolylcarboxypeptidase as an endothelial cell prekallikrein activator

Z Shariat-Madar, F Mahdi, AH Schmaier - Journal of Biological Chemistry, 2002 - ASBMB
Our recent investigations have postulated a human umbilical vein endothelial cell (HUVEC)-
associated prekallikrein activator (PKA). When prekallikrein (PK) assembles on high …